BioSpace News Archive

Data provided by Lucintel projects that the future of the global medical device industry will provide opportunities in public and private hospitals.

Phreesia, the nation’s leading patient intake management platform, is pleased to announce it has named Mark Smith, MD, MBA, as the newest member of its board of directors, effective immediately.

CVS Health Corporation (NYSE: CVS) will be holding a conference call on Tuesday, November 6, 2018, at 8:30 a.m. (ET) with analysts and investors to discuss its third quarter financial results.

VistaGen Therapeutics Inc (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) diseases and disorders with high unmet need, today announced that the Company has exercised its option to acquire from Pherin Pharmaceuticals, Inc.

Ultragenyx Pharmaceutical Inc.(NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases, today announced its Phase 3 study of UX007 in patients with glucose transporter type-1 deficiency syndrome

Lindsay Norris, RN, is the third University of Kansas Hospital nurse to receive the prestigious industry award in the past six years

Aspire Fertility-San Antonio is proud to welcome the newest member of the fertility team, Summer James, MD, FACOG. Dr. James joins fellow Reproductive Endocrinologists Francisco Arredondo, Aimee Brown, Ursula Balthazar, Courtney Failor, Lab Director Tony Anderson, and a caring support staff who help each patient navigate their fertility journey.

Sustained protein expression levels at six months reported in Cohort 3

Nation’s Largest, Most Established Barre Franchise Marks Xponential’s Seventh Acquisition

Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the quarter and half year ended September 30, 2018 under International Financial Reporting Standards (IFRS).